Susquehanna International Group, LLP Dice Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 11, 2023	BUY	$25.86 - $46.71 $550,818 - $994,923	21,300 Added 226.6%	30,700 $1.43 Million
Q1 2023 May 16, 2023	BUY	$26.05 - $32.31 $244,870 - $303,714	9,400 New	9,400 $269,000
Q3 2022 Nov 14, 2022	BUY	$14.97 - $22.65 $408,681 - $618,345	27,300 New	27,300 $554,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.